Featured Stories
New treatment of Duchenne muscular dystrophy
Italfarmaco and Medis Announce Exclusive Distribution Agreement for Givinostat in 17 Central and Eastern European Countries including the Baltic States
Givinostat has already received regulatory approval in the US and UK, with an evaluation ongoing by the European Medicines Agency (EMA).
Read More
Celebration of Outstanding research achievements
Winners of the 11th International Medis Awards for Medical Research announced
The President of the Republic of Slovenia Nataša Pirc Musar, PhD, was the honorary speaker at the ceremony.
Read More
Recognition for Excellence in the Workplace
Medis Wins the Prestigious German Economy Award 2024/25
The company Medis has been awarded the German Economy Award 2024/25 in the category "Excellent Employer".
Read More
Award for outstanding achievements in management
Artemis 2024 Award to Maja Strnad Cestar
The award is presented annually by the Association of Managers to managers in Slovenia.
Read More
Commercialization of WAYA Biotic D3 drops
New Partnership with Faes Pharma Portugal
We are proud to announce a new partnership with Faes Farma Portugal for the commercialization of WAYA Biotic D3 drops under the brand name Gut4Neo.
Read More
INTERVIEW WITH MEDIS CEO MAJA STRNAD CESTAR
We Open The Doors For New Therapies
Celebrating 35 years of innovation, growth, and patient-focused solutions in healthcare across 18 European countries.
Read More